Gabapentin use and a claim for memory loss in Missouri

Missouri's pharmaceutical litigation significance stems from St. Louis City's reputation as one of the most plaintiff-favorable venues in the nation and the state's concentration of mass tort litigation experience. Missouri's gabapentin prescribing rates are elevated in the rural Ozark region and the Boot Heel, where chronic pain from agricultural labor and limited specialist access drive pharmaceutical pain management reliance. Missouri was the last state in the nation to establish a prescription drug monitoring program (implemented 2017), meaning years of gabapentin prescribing occurred without any statewide tracking — a gap that may have enabled overprescribing and made it impossible for physicians to identify patients receiving gabapentin from multiple providers.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Missouri.